Bluejay Diagnostics, Inc. · NASDAQ:BJDX
Bluejay Diagnostics, Inc. shareholders
As of Sep 30, 2026, 14 institutions reported holding Bluejay Diagnostics, Inc., 18.8% of its shares. Largest: Citadel, Jane Street and Geode Capital. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Bluejay Diagnostics, Inc. | Change | Filed |
|---|---|---|---|---|
| Citadel | 54,764 | 4.9% | new | Nov 16, 2026 |
| Jane Street | 43,895 | 3.9% | new | Nov 12, 2026 |
| Geode Capital | 39,602 | 3.5% | new | Nov 6, 2026 |
| Susquehanna | 27,684 | 2.5% | new | Nov 16, 2026 |
| StoneX Group Inc. | 17,828 | 1.6% | new | Nov 3, 2026 |
| Virtu Financial LLC | 12,027 | 1.1% | new | Nov 17, 2026 |
| Vanguard | 10,225 | 0.92% | no change | Nov 13, 2026 |
| Tower Research Capital LLC (TRC) | 2,933 | 0.26% | +1,026 | Nov 16, 2026 |
| UBS | 596 | 0.05% | new | Nov 10, 2026 |
| SBI Securities Co., Ltd. | 302 | 0.03% | new | Oct 21, 2026 |